Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemours (CC) Invested Capital (2016 - 2025)

Historic Invested Capital for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $352.0 million.

  • Chemours' Invested Capital fell 4957.02% to $352.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $352.0 million, marking a year-over-year decrease of 4957.02%. This contributed to the annual value of $642.0 million for FY2024, which is 1863.12% down from last year.
  • As of Q3 2025, Chemours' Invested Capital stood at $352.0 million, which was down 4957.02% from $277.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' Invested Capital registered a high of $4.7 billion during Q2 2022, and its lowest value of $277.0 million during Q2 2025.
  • Over the past 5 years, Chemours' median Invested Capital value was $852.0 million (recorded in 2023), while the average stood at $1.6 billion.
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 43965.71% in 2022, then tumbled by 8273.52% in 2023.
  • Quarter analysis of 5 years shows Chemours' Invested Capital stood at $4.7 billion in 2021, then decreased by 2.06% to $4.6 billion in 2022, then tumbled by 82.74% to $789.0 million in 2023, then dropped by 18.63% to $642.0 million in 2024, then plummeted by 45.17% to $352.0 million in 2025.
  • Its last three reported values are $352.0 million in Q3 2025, $277.0 million for Q2 2025, and $623.0 million during Q1 2025.